Established in Singapore in 1989, Research Instruments Group employs approximately 100 people in SE Asia catering to our customers in the fields of life science research, pharmaceuticals and health supplements, food and agriculture, chemicals, polymers and materials, and electronics and semiconductor.

RI has been a pioneer in introducing new instrument techniques and research tools into the region by organizing seminars and workshops with scientists and engineers from overseas universities, institutions and companies. Since 1989, RI organized and hosted some of the first commercial seminars and workshops in advanced technologies. Some of these technologies included AFM, DNA & peptide synthesis, MALDI-TOF MS, MS-MS for protein sequencing, 2-D electrophoresis, FT-Raman spectroscopy, Nano-LC, LC-MS-MS, microarray spotting and scanning, RNAi technology, cellular imaging etc.



EXECUTIVE MANAGEMENT

	Gregor Kent, Chief Executive Officer Mr Gregor Kent, the principal founder of the company, has led the company since its inception in 1989. Before starting the Research Instruments group of companies, he has studied chemistry at the University of Massachusetts after which he began his career with Waters Inc. in the USA, eventually holding various management positions in service and sales during his career with Waters and Millipore in both Europe and Asia. Since 1989, Mr. Kent has been leading and building the RI group of companies including Research Instruments Pte Ltd (Singapore), Research Instruments Sdn Bhd (Malaysia), RI Technologies Ltd (Thailand), and most recently Origen Laboratories Pte Ltd (Singapore).
	Eric Tay, Chief Financial Officer Mr Eric Tay joined the company as the chief financial officer in 2004. Prior to joining the company, he was the regional financial controller for Mobile 365 (now Sybase 365), leader in the global delivery and settlement of mobile messaging interoperability, and the management and distribution of mobile content. He also has 10 years’ working experience in a CPA firm – Lo Hock Ling & Co, an independent member of Polaris International, where he was a senior manager. His experience then included audit, tax, accounting services, financial and IT consultancy. Eric is a fellow member of Institute of Certified Public Accountants of Singapore and Association of Chartered Certified Accountants (UK).
	Thomas J Murphy, Chief Scientific Officer (Life Sciences) Dr. Thomas Murphy is a cell biologist with over 10 years' experience in molecular cell biology and target identification and validation. His particular research interests include biological imaging, cell signaling, and angiogenesis. Prior to joining Research Instruments, Dr. Murphy worked as an Applications Scientist at Thermo Fisher Scientific Dharmacon® RNAi Technology, to advise fellow scientists on advancements being made in the field of RNA interference. During his post-doctoral fellowship, he worked at the Novartis Institute for Functional Genomics (GNF) in San Diego, where he was responsible for conceiving and implementing siRNA-based genomic screens against inflammatory and oncology pathways. He received his B.A. in Biology from Occidental College, followed by his Ph.D. from the Molecular Biology Institute at University of California, Los Angeles. He has also held research positions at UC San Francisco and Amgen Inc.